Recent data have implicated thrombospondin-1 (TSP-1) signaling in the acute neuropathological events that occur in microvascular endothelial cells (ECs) following spinal cord injury (SCI) (Benton et al., 2008b). We hypothesized that deletion of TSP-1 or its receptor CD47 would reduce these pathological events following SCI. CD47 is expressed in a variety of tissues, including vascular ECs and neutrophils. CD47 binds to TSP-1 and inhibits angiogenesis. CD47 also binds to the signal regulatory protein (SIRP)α and facilitates neutrophil diapedesis across ECs to sites of injury. After contusive SCI, TSP-1 −/− mice did not show functional improvement compared to wildtype (WT) mice. CD47 −/− mice, however, exhibited functional locomotor improvements and greater white matter sparing. Whereas targeted deletion of either CD47 or TSP-1 improved acute epicenter vascularity in contused mice, only CD47 deletion reduced neutrophil diapedesis and increased microvascular perfusion. An ex vivo model of the CNS microvasculature revealed that CD47 −/− -derived microvessels (MVs) prominently exhibit adherent WT or CD47 −/− neutrophils on the endothelial lumen, whereas WT-derived MVs do not. This implicates a defect in diapedesis mediated by the loss of CD47 expression on ECs. In vitro transmigration assays confirmed the role of SIRPα in neutrophil diapedesis through EC monolayers. We conclude that CD47 deletion modestly, but significantly, improves functional recovery from SCI via an increase in vascular patency and a reduction of SIRPα-mediated neutrophil diapedesis, rather than the abrogation of TSP-1-mediated anti-angiogenic signaling.
Introduction
Contusive SCI leads to a cascade of secondary complications including loss of spinal microvasculature and innate inflammatory responses. These secondary responses contribute to cell death, axonal degeneration, and demyelination within the contusion and injury penumbra (Alexander and Popovich, 2009; Mautes et al., 2000) . The onset of vascular pathology following injury is rapid and restricted to the injury epicenter (Benton et al., 2008a; Casella et al., 2006; Goodman et al., 1979; Griffiths et al., 1978; Whetstone et al., 2003) . Early vessel dysfunction and increased permeability of the bloodspinal cord-barrier (BSCB) induces edema and contributes to the initiation of inflammation (Amar and Levy, 1999; Mautes et al., 2000; Popovich and Longbrake, 2008) . Delayed pathological transformation of the spinal microvasculature at penumbral sites occurs following a loss of astrocytic investment (Whetstone et al., 2003) , regression of pericytes (Benton et al., 2008a) and the delayed perivascular localization of progressive waves of infiltrating inflammatory cells (Fleming et al., 2006; Popovich and Jones, 2003) . Infiltrating leukocytes mediate tissue damage via the production of oxygen radicals, cytokines and chemokines (Tonnesen et al., 1988) . Blocking neutrophil and macrophage influx into the SCI leads to neuroprotection and improved locomotor function (Giulian and Robertson, 1990; Gris et al., 2004; Popovich and Jones, 2003 ). An initial loss of nearly all epicenter vasculature is followed by a prolific angiogenic response from days 3 to 7 post-SCI (Benton et al., 2008a; Casella et al., 2002; Loy et al., 2002; Wagner et al., 1977; Whetstone et al., 2003) . These new vessels are immature and leaky. In the mouse, the epicenter eventually evolves into a mesenchymal, aglial heterodomain. This second phase of microvascular instability has been hypothesized to contribute to chronic histopathology following traumatic SCI (Casella et al., 2002; Loy et al., 2002; Wagner et al., 1977) . Indeed, rescue of ECs and stabilization of the microvasculature within the contusion epicenter and penumbra facilitates tissue sparing and functional recovery following SCI (Han et al., 2010) . Neurobiology of Disease 42 (2011) 21-34 
